Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Clin Pharmacol. 2011 Dec 12;52(11):1624–1644. doi: 10.1177/0091270011421911

Figure 6.

Figure 6

Simulated hemoglobin vs time profile for the TIW and QW IV and SC dosing regimens for HX575 and the comparator. Fixed effect model parameters for HX575 and the comparator were used in the simulation.